Researchers Discover COVID-19’s Secret to Evading Early Immune Response
The virus takes control of three key host proteins that suppress the activity of the complement system. Researchers at the ...
Tagging antibiotic-resistant bacteria with a chimeric agent to activate the immune system
Researchers at the Hebrew University of Jerusalem have developed an innovative approach to fight antibiotic-resistant ...
MyChesCo on MSN8d
Ocugen Reports Promising Results from OCU410 ArMaDa Trial for Geographic Atrophy
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has unveiled encouraging preliminary data from the Phase 1 portion of its OCU410 ...
Annexon Biosciences: Promising Phase 3 Results and Pipeline Potential Justify Buy Rating
Annexon Biosciences (ANNX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Andrew ...
Annexon Biosciences: Buy Rating Backed by Promising Data Releases and Strategic Long-term Potential
Needham analyst Joseph Stringer maintained a Buy rating on Annexon Biosciences (ANNX – Research Report) today and set a price target of ...
News Medical on MSN13d
Chimeric tagging technique offers new hope in the fight against drug-resistant infections
A new study has developed an innovative approach to combat antibiotic-resistant bacteria by tagging them with a chimeric agent that activates the immune system towards them.
Nature6y
Alcon licenses complement pathway inhibitor for macular degeneration
The eye-care company Alcon Research has entered into licensing and purchase option agreements with Potentia Pharmaceuticals to develop Potentia's leading drug candidate — a complement pathway ...
Nature5y
78 Differential Role of the Lectin Pathway of Complement Activation in Susceptibility to Neonatal Sepsis
Mannan-binding lectin (MBL), M-, L- and H-ficolin recognize microorganisms and activate the complement system via MBL-associated serine proteases (MASPs). We investigated lectin pathway cord blood ...